# Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules

> **NCT03502070** · PHASE4 · COMPLETED · sponsor: **Mylan Inc.** · enrollment: 47 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Placebo
- **DEVICE:** Tobi Podhaler

## Key facts

- **NCT ID:** NCT03502070
- **Lead sponsor:** Mylan Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-26
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-06-17
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03502070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03502070, "Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03502070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*